AME Ametek
Excellent operator of niche industrials; real moat, zero margin of safety at current price.
The business
AMETEK manufactures precision electronic instruments and electromechanical devices for industrial, aerospace, defense, and medical customers. It grows primarily via a disciplined serial-acquisition strategy—buying niche industrial businesses, applying its operating system (AMETEK Business System), and expanding margins. Organic growth runs ~4-5%; M&A contributes the balance.
Quality gate · 76/100
Moat & management
| Moat | narrow moat |
| Source | switching costs |
| Trajectory | stable |
| Management | excellent |
Precision instruments and engineered components embedded in critical customer processes carry high switching costs—recertification, process revalidation, and engineering risk all discourage vendor changes. AMETEK also accumulates intangible know-how and niche #1/#2 market positions in many verticals. However, the moat is acquirer-dependent: sustaining returns requires a continuous pipeline of attractively priced deals, and competition from Danaher, Roper, and private equity has made that harder.
Capex at 1.7% of revenue reflects disciplined asset-light stewardship; FCF conversion above 1.0x confirms earnings quality. Balance sheet conservatism (net debt/EBITDA 0.8x) gives dry powder for deals without stress. Share count barely moves, buybacks are opportunistic rather than ego-driven. The risk is that the M&A model pressures management to deploy capital even when deal pricing is full.
Owner-earnings inputs
| Owner earnings (TTM) | 1.70B |
| Owner-earnings yield | 3.1% |
| Free-cash-flow yield | 3.1% |
| Growth used (normalized) | 6.0% |
| Market-implied growth (reverse DCF) | 6.9% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 9.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 1.81B | 6.0% | 1.66B |
| 2 | 1.91B | 5.7% | 1.61B |
| 3 | 2.01B | 5.3% | 1.55B |
| 4 | 2.11B | 5.0% | 1.49B |
| 5 | 2.21B | 4.7% | 1.44B |
| 6 | 2.30B | 4.3% | 1.37B |
| 7 | 2.40B | 4.0% | 1.31B |
| 8 | 2.48B | 3.7% | 1.25B |
| 9 | 2.57B | 3.3% | 1.18B |
| 10 | 2.64B | 3.0% | 1.12B |
Key risks
- M&A treadmill: sustaining growth requires continuously finding and integrating acquisitions at acceptable prices in an increasingly competitive deal market
- Industrial cycle exposure—revenue and margins compress meaningfully in downturns, as seen across AMETEK's end markets
- Valuation leaves no margin of safety; the stock is priced for a decade of flawless execution
Catalysts
- Defense and aerospace spending upcycle lifts a meaningful revenue segment
- Post-acquisition margin improvement as AMETEK Business System is applied to recent deals
Recent news
score · 8 articles
- Are Computer and Technology Stocks Lagging Flex (FLEX) This Year?
- Is AMETEK Stock Just More Market Exposure?
- Top 3D Printing Stocks to Buy Now for Solid Long-Term Returns
- Giverny Capital Asset Management Sold Ametek (AME) Due to Valuation Gap
- Top Research Reports for Pfizer, Altria & Newmont Corp.
- How Is Rockwell Automation's Stock Performance Compared to Other Industrial Stocks?
- How Is AMETEK's Stock Performance Compared to Other Industrial Stocks?
- M.D. Sass Exits Sallie Mae -- Selling Its Entire $33.1 Million Stake
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF